Autoimmune Diseases, Cardiovascular Diseases, Gastro-Intestinal Disorder, Genitourinary Disease, Hematologic Malignancy, Infectious Disease, Oncology, Pregnancy Related, Renal Disease
Conditions
Brief summary
Study purpose: to explore the entire spectrum of proteomic and genomic changes (amongst others) involved in diseases and in healthy/control populations. The Study is designed to discover biomarkers, develop and validate diagnostic assays, instruments and therapeutics as well as other medical research. Specifically, researchers may analyze proteins, RNA, DNA copy number changes, including large and small (1,000-100,000 kb) scale rearrangements, transcription profiles, epigenetic modifications, sequence variation, and sequence in both diseased tissue and case-matched germline DNA from Subjects.
Detailed description
The primary objective of this Study is to collect high-quality tissue, whole teeth, and biofluid Specimens, and associated Clinical Data from consented Subjects. The secondary objective of this Study is to test Specimens and associated Clinical Data to confirm pathology diagnosis and correlation of microscopic evaluation with the provided information, to assess RNA and DNA integrity or degradation, and provide overall quality control evaluations.
Interventions
OTHERObservational Study Only. NO Intervention.
Observational Study Only. NO Intervention.
Sponsors
Audubon Bioscience
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
1. Subject shall be at least 18 years of age, or higher if required by Applicable Law. 2. Subject's Clinical Data shall be relevant to the Study in which he/she is participating. 3. Subject shall understand and voluntarily sign the ICF prior to the Study participation. If the Subject is illiterate, the witness must sign the ICF (see 5.6. for details). If the Subject is incapable of consenting himself/herself, the legally authorized representative must sign the ICF (see 5.6. for details). 4. Subject shall meet any other additional inclusion criteria specified in Appendices to this Protocol, or in additional written instructions of the Sponsor. 5. Subject shall be able to donate the requested Specimen(s) without compromising his/her current health status.
Exclusion criteria
1. Younger than 18 years of age, or higher if required by Applicable Law. 2. The individual is incapable of understanding the items listed in the ICF and the consent process unless consented by the legally authorized representative. 3. Prisoner
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Enrollment and collection totals for a diverse population of subjects/conditions involved in diseases and in healthy/control populations. | Through study completion, an average of once per year | We will total the number of subjects and characterize the totals by disease state, gender, ethnicity and specimens contributed |
Countries
United States
Outcome results
None listed